Table 2.

Distribution of causes of death by time between diagnosis and death, separately for the United States and Sweden*

Mortality status	Swedish Cancer Registry (n = 210 112)			US SEER Registry (n = 490 341)
	Men with <5 y of follow-up	Men with 5–10 y of follow-up	Men with >10 y of follow-up	Men with <5 y of follow-up	Men with 5–10 y of follow-up	Men with >10 y of follow-up
No. at risk†	210 112	81 914	27 776	490 341	265 368	121 274
Alive throughout    follow-up, No. (%)‡	37 620 (17.9)	20 119 (24.6)	9184 (33.1)	94 890 (19.4)	71 042 (26.8)	65 388 (53.9)
All deaths, No. (%)	90 578 (43.1)	34 019 (41.5)	18 592 (66.9)	130 083 (26.5)	73 052 (27.5)	55 886 (46.1)
Cause-specific    death, No. (%)§
Prostate cancer	51 342 (56.7)	15 809 (46.5)	6678 (35.9)	47 541 (36.5)	19 486 (26.7)	11 037 (19.7)
IHD	14 368 (15.9)	5853 (17.2)	3535 (19.0)	29 507 (22.7)	18 057 (24.7)	14 615 (26.2)
Cerebrovascular disease	4115 (4.5)	2150 (6.3)	1346 (7.2)	5854 (4.5)	3961 (5.4)	3223 (5.8)
Other cancers	5319 (5.9)	2408 (7.1)	1350 (7.3)	19 486 (15.0)	11 300 (15.5)	7993 (14.3)
COPD	1210 (1.3)	593 (1.7)	385 (2.1)	4408 (3.4)	2914 (4.0)	2340 (4.2)
Diabetes	527 (0.6)	298 (0.9)	206 (1.1)	1564 (1.2)	1201 (1.6)	1007 (1.8)
External causes‖	1438 (1.6)	656 (1.9)	419 (2.3)	2472 (1.9)	1639 (2.2)	1254 (2.2)
Other specified causes¶	12 259 (13.5)	6252 (18.4)	4673 (25.1)	19 251 (14.8)	14 494 (19.8)	14 417 (25.8)

*SEER = Surveillance, Epidemiology, and End Results; IHD = ischemic heart disease; COPD = chronic obstructive pulmonary disease.

†Number of men alive at the beginning of follow-up window.

‡Men alive at the beginning of the follow-up window who did not die during the specified period of follow-up.

§Percentage of all deaths.

‖Death caused by external causes, including suicide and trauma.

¶Deaths from causes not previously categorized in this analysis, including infectious diseases and liver disease.